| EARNINGS (LOSS) PER SHARE |
Note 20 – EARNINGS (LOSS) PER SHARE Basic earnings (loss) per share is the amount of net earnings available to each share of ordinary shares outstanding during the reporting period. Diluted EPS is the amount of net earnings available to each share of ordinary shares outstanding during the reporting period adjusted to include the effect of potentially dilutive ordinary shares. The following table details the outstanding shares for basic and diluted net earnings per share: | | | For the years ended March 31, | | | | | 2026 | | | 2025 | | | 2024 | | | Numerator: | | | | | | | | | | | Net loss from continuing operation attributable to Akso Health Group’s shareholder | | $ | (18,671,610 | ) | | $ | (134,977,369 | ) | | $ | (9,058,986 | ) | | Net loss from discontinued operation attributable to Akso Health Group’s shareholders | | | — | | | | —— | | | | (399,798 | ) | | Net loss attributable to Akso Health Group’s shareholders | | $ | (18,671,610 | ) | | $ | (134,977,369 | ) | | $ | (9,458,784 | ) | | | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | | | Weighted average number of ordinary shares outstanding—basic | | | 2,168,121,761 | | | | 855,288,335 | | | | 141,516,777 | | | Weighted average number of dilutive potential ordinary shares from share options | | | — | | | | — | | | | — | | | Weighted average number of ordinary shares outstanding—diluted | | | 2,168,121,761 | | | | 855,288,335 | | | | 141,516,777 | | | | | | | | | | | | | | | | | Basic (loss) per common share | | $ | (0.01 | ) | | $ | (0.16 | ) | | $ | (0.07 | ) | | Diluted (loss) per common share | | $ | (0.01 | ) | | $ | (0.16 | ) | | $ | (0.07 | ) |
|